484 related articles for article (PubMed ID: 16178513)
21. Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells.
Arbusow V; Derfuss T; Held K; Himmelein S; Strupp M; Gurkov R; Brandt T; Theil D
J Med Virol; 2010 Nov; 82(11):1917-20. PubMed ID: 20872719
[TBL] [Abstract][Full Text] [Related]
22. Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency.
Minagawa H; Yanagi Y
Arch Virol; 2000; 145(11):2259-72. PubMed ID: 11205116
[TBL] [Abstract][Full Text] [Related]
23. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
van Velzen M; Jing L; Osterhaus AD; Sette A; Koelle DM; Verjans GM
PLoS Pathog; 2013 Aug; 9(8):e1003547. PubMed ID: 23966859
[TBL] [Abstract][Full Text] [Related]
24. Does the latency associated transcript (LAT) of herpes simplex virus (HSV) function as a ribozyme during viral reactivation?
Hui EK; Lo SJ
Virus Genes; 1998; 16(2):147-8. PubMed ID: 9608658
[TBL] [Abstract][Full Text] [Related]
25. Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia.
Hüfner K; Derfuss T; Herberger S; Sunami K; Russell S; Sinicina I; Arbusow V; Strupp M; Brandt T; Theil D
J Neuropathol Exp Neurol; 2006 Oct; 65(10):1022-30. PubMed ID: 17021407
[TBL] [Abstract][Full Text] [Related]
26. Glutamine supplementation suppresses herpes simplex virus reactivation.
Wang K; Hoshino Y; Dowdell K; Bosch-Marce M; Myers TG; Sarmiento M; Pesnicak L; Krause PR; Cohen JI
J Clin Invest; 2017 Jun; 127(7):2626-2630. PubMed ID: 28581445
[TBL] [Abstract][Full Text] [Related]
27. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
Sekizawa T; Openshaw H; Itoyama Y
J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission.
Mertz GJ
J Infect Dis; 2008 Oct; 198(8):1098-100. PubMed ID: 18783317
[No Abstract] [Full Text] [Related]
29. Animal models of herpes simplex virus immunity and pathogenesis.
Kollias CM; Huneke RB; Wigdahl B; Jennings SR
J Neurovirol; 2015 Feb; 21(1):8-23. PubMed ID: 25388226
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus latency.
Lachmann R
Expert Rev Mol Med; 2003 Dec; 5(29):1-14. PubMed ID: 14987404
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.
Kimura H; Ito Y; Futamura M; Ando Y; Yabuta Y; Hoshino Y; Nishiyama Y; Morishima T
J Med Virol; 2002 Jul; 67(3):349-53. PubMed ID: 12116026
[TBL] [Abstract][Full Text] [Related]
32. [Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells].
Sun Z; Yang H; Shi Y; Wei M; Xian J; Hu W
Wei Sheng Wu Xue Bao; 2010 Jan; 50(1):98-106. PubMed ID: 20344947
[TBL] [Abstract][Full Text] [Related]
33. Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model.
Miller CG; Fraser NW
Cancer Res; 2000 Oct; 60(20):5714-22. PubMed ID: 11059765
[TBL] [Abstract][Full Text] [Related]
34. Immunity to latent viral infection: many skirmishes but few fatalities.
Khanna KM; Lepisto AJ; Hendricks RL
Trends Immunol; 2004 May; 25(5):230-4. PubMed ID: 15099562
[No Abstract] [Full Text] [Related]
35. Herpes simplex virus type-1 latency inhibits dendritic growth in sympathetic neurons.
Hamza MA; Higgins DM; Ruyechan WT
Neurobiol Dis; 2006 Nov; 24(2):367-73. PubMed ID: 16952455
[TBL] [Abstract][Full Text] [Related]
36. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review.
Spiegel R; Miron D; Yodko H; Lumelsky D; Habib A; Horovitz Y
J Child Neurol; 2008 Mar; 23(3):344-8. PubMed ID: 18230840
[TBL] [Abstract][Full Text] [Related]
37. 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells.
Kim YH; Seo SK; Choi BK; Kang WJ; Kim CH; Lee SK; Kwon BS
Cell Immunol; 2005 Dec; 238(2):76-86. PubMed ID: 16524567
[TBL] [Abstract][Full Text] [Related]
38. Tipping the scales of herpes simplex virus reactivation: the important responses are local.
Posavad CM; Koelle DM; Corey L
Nat Med; 1998 Apr; 4(4):381-2. PubMed ID: 9546773
[No Abstract] [Full Text] [Related]
39. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
40. Latent herpes simplex virus 1 infection does not induce apoptosis in human trigeminal Ganglia.
Himmelein S; Lindemann A; Sinicina I; Strupp M; Brandt T; Hüfner K
J Virol; 2015 May; 89(10):5747-50. PubMed ID: 25762734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
